Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma
Open Access
- 20 February 2006
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 38
Abstract
Leptin (LEP) has been consistently associated with angiogenesis and tumor growth. Leptin exerts its physiological action through its specific receptor (LEPR). We have investigated whether genetic variations in LEP and LEPR have implications for susceptibility to and prognosis in breast carcinoma. We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the LEP and LEPR genes in 308 unrelated Tunisian patients with breast carcinoma and 222 healthy control subjects. Associations of the clinicopathologic parameters and these genetic markers with the rates of the breast carcinoma-specific overall survival (OVS) and the disease free survival (DFS) were assessed using univariate and multivariate analyses. A significantly increased risk of breast carcinoma was associated with heterozygous LEP (-2548) GA (OR = 1.45; P = 0.04) and homozygous LEP (-2548) AA (OR = 3.17; P = 0.001) variants. A highly significant association was found between the heterozygous LEPR 223QR genotype (OR = 1.68; P = 0.007) or homozygous LEPR 223RR genotype (OR = 2.26; P = 0.001) and breast carcinoma. Moreover, the presence of the LEP (-2548) A allele showed a significant association with decreased disease-free survival in breast carcinoma patients, and the presence of the LEPR 223R allele showed a significant association with decreased overall survival. Our results indicated that the polymorphisms in LEP and LEPR genes are associated with increased breast cancer risk as well as disease progress, supporting our hypothesis for leptin involvement in cancer pathogenesis.Keywords
This publication has 85 references indexed in Scilit:
- Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer?Journal of Clinical Oncology, 2005
- Leptin: A proliferative factor for breast cancer?Biochemical and Biophysical Research Communications, 2005
- Leptin mediates a proliferative response in human MCF7 breast cancer cellsBiochemical and Biophysical Research Communications, 2002
- Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitroExperimental & Molecular Medicine, 2001
- A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian womenHuman Genetics, 2001
- Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3‐kinase‐, Rho‐, and Rac‐dependent signaling pathwaysThe FASEB Journal, 2000
- Blood to Brain Transfer of Leptin in Normal and Interleukin-1 -Treated Male RatsEndocrinology, 2000
- A role for leptin and its cognate receptor in hematopoiesisCurrent Biology, 1996
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958